- Home
- RPRX vs MAA Comparison
RPRX vs MAA Comparison
Compare RPRX & MAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- MAA
- Stock Information
- Founded
- RPRX 1996
- MAA 1977
- Country
- RPRX United States
- MAA United States
- Employees
- RPRX N/A
- MAA N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- MAA Real Estate Investment Trusts
- Sector
- RPRX Health Care
- MAA Real Estate
- Exchange
- RPRX Nasdaq
- MAA Nasdaq
- Market Cap
- RPRX 15.6B
- MAA 16.6B
- IPO Year
- RPRX 2020
- MAA 1994
- Fundamental
- Price
- RPRX $37.03
- MAA $132.48
- Analyst Decision
- RPRX Strong Buy
- MAA Buy
- Analyst Count
- RPRX 4
- MAA 19
- Target Price
- RPRX $44.50
- MAA $161.79
- AVG Volume (30 Days)
- RPRX 3.5M
- MAA 778.0K
- Earning Date
- RPRX 11-05-2025
- MAA 10-29-2025
- Dividend Yield
- RPRX 2.38%
- MAA 4.57%
- EPS Growth
- RPRX 54.86
- MAA 10.39
- EPS
- RPRX 2.32
- MAA 4.85
- Revenue
- RPRX $2,305,243,000.00
- MAA $2,200,155,000.00
- Revenue This Year
- RPRX $35.14
- MAA $1.92
- Revenue Next Year
- RPRX $1.24
- MAA $3.09
- P/E Ratio
- RPRX $15.92
- MAA $27.34
- Revenue Growth
- RPRX 3.02
- MAA 1.19
- 52 Week Low
- RPRX $24.05
- MAA $131.17
- 52 Week High
- RPRX $38.00
- MAA $173.38
- Technical
- Relative Strength Index (RSI)
- RPRX 61.20
- MAA 32.17
- Support Level
- RPRX $35.23
- MAA $131.17
- Resistance Level
- RPRX $36.36
- MAA $137.69
- Average True Range (ATR)
- RPRX 0.63
- MAA 1.78
- MACD
- RPRX 0.11
- MAA -0.34
- Stochastic Oscillator
- RPRX 95.38
- MAA 14.98
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.